These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33581708)

  • 21. [Analysis of non-invasive prenatal screening detection in fetal chromosome aneuploidy].
    Cai AJ; Zhu CF; Xue SW; Cui SY; Qu SZ; Liu N; Kong XD
    Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):765-769. PubMed ID: 29179272
    [No Abstract]   [Full Text] [Related]  

  • 22. Patient choice and clinical outcomes following positive noninvasive prenatal screening for aneuploidy with cell-free DNA (cfDNA).
    Dobson LJ; Reiff ES; Little SE; Wilkins-Haug L; Bromley B
    Prenat Diagn; 2016 May; 36(5):456-62. PubMed ID: 26938930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. State-wide utilization and performance of traditional and cell-free DNA-based prenatal testing pathways: the Victorian Perinatal Record Linkage (PeRL) study.
    Lindquist A; Hui L; Poulton A; Kluckow E; Hutchinson B; Pertile MD; Bonacquisto L; Gugasyan L; Kulkarni A; Harraway J; Howden A; McCoy R; Da Silva Costa F; Menezes M; Palma-Dias R; Nisbet D; Martin N; Bethune M; Poulakis Z; Halliday J
    Ultrasound Obstet Gynecol; 2020 Aug; 56(2):215-224. PubMed ID: 31625225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
    Suzumori K; Tanemura M; Murakami I; Okada S; Natori M; Tanaka M; Takagi T; Sato A
    Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population-based trends in prenatal screening and diagnosis for aneuploidy: a retrospective analysis of 38 years of state-wide data.
    Hui L; Muggli EE; Halliday JL
    BJOG; 2016 Jan; 123(1):90-7. PubMed ID: 26108969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Introduction of cell-free DNA screening is associated with changes in prenatal genetic counseling indications.
    Stevens BK; Noblin SJ; Chen HY; Czerwinski J; Friel LA; Wagner C
    J Genet Couns; 2019 Jun; 28(3):692-699. PubMed ID: 30791172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implementation of cell-free DNA-based non-invasive prenatal testing in a National Health Service Regional Genetics Laboratory.
    Togneri FS; Kilby MD; Young E; Court S; Williams D; Griffiths MJ; Allen SK
    Genet Res (Camb); 2019 Dec; 101():e11. PubMed ID: 31813398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multicenter study of fetal chromosomal abnormalities in Chinese women of advanced maternal age.
    Zhu Y; Lu S; Bian X; Wang H; Zhu B; Wang H; Xu Z; Xu L; Yan W; Zeng Y; Chen Z; Tang S; Shen G; Miao Z
    Taiwan J Obstet Gynecol; 2016 Jun; 55(3):379-84. PubMed ID: 27343319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China.
    Liu Y; Liu H; He Y; Xu W; Ma Q; He Y; Lei W; Chen G; He Z; Huang J; Liu J; Liu Y; Huang Q; Yu F
    Hum Genomics; 2020 Jun; 14(1):21. PubMed ID: 32503639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
    Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
    Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Committee Opinion No. 640: Cell-Free DNA Screening For Fetal Aneuploidy.
    Obstet Gynecol; 2015 Sep; 126(3):e31-e37. PubMed ID: 26287791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of clinical and cytogenetic findings on 1,068 second-trimester amniocenteses in Southeast Turkey.
    Balkan M; Akbas H; Kalkanli S; Sakar MN; Fidanboy M; Alp MN; Budak T
    Clin Exp Obstet Gynecol; 2011; 38(4):364-8. PubMed ID: 22268276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of indications and results of prenatal invasive diagnostic tests before and after the implementation of the use of cell-free fetal DNA: a tertiary referral center experience.
    Okmen F; Ekici H; Hortu I; Imamoglu M; Arican D; Akın H; Sagol S
    J Assist Reprod Genet; 2020 Aug; 37(8):2019-2024. PubMed ID: 32440934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ultrasound screening for Down syndrome and other chromosomal abnormalities by fetal nuchal translucency measurement between 11-14 weeks of gestation].
    Dimitrova V; Markov D; Chernev T; Karag'ozova Zh; Mazneĭkova V; Andonova S; Vŭzharova R
    Akush Ginekol (Sofiia); 2005; 44(1):32-7. PubMed ID: 15853009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome].
    Kjaergaard S; Hahnemann JM; Skibsted L; Jensen LN; Sperling L; Zingenberg H; Kristiansen A; Brøndum-Nielsen K
    Ugeskr Laeger; 2008 Mar; 170(14):1152-6. PubMed ID: 18405480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of non-invasive prenatal testing as a contingent approach on the indications for invasive prenatal diagnosis and prenatal detection rate of Down's syndrome.
    Kou KO; Poon CF; Kwok SL; Chan KY; Tang MH; Kan AS; Leung KY
    Hong Kong Med J; 2016 Jun; 22(3):223-30. PubMed ID: 27149976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [What are the real purpose and scope of screening for aneuploidy?].
    Quibel T; Rozenberg P
    Gynecol Obstet Fertil Senol; 2018 Feb; 46(2):124-129. PubMed ID: 29396076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Committee Opinion Summary No. 640: Cell-Free DNA Screening For Fetal Aneuploidy.
    Obstet Gynecol; 2015 Sep; 126(3):691-692. PubMed ID: 26287784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic counseling, prenatal screening and diagnosis of Down syndrome in the second trimester in women of advanced maternal age: a prospective study.
    Qi QW; Jiang YL; Zhou XY; Liu JT; Yin J; Bian XM
    Chin Med J (Engl); 2013; 126(11):2007-10. PubMed ID: 23769548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors affecting parental decisions to terminate pregnancy in the presence of chromosome abnormalities: a Japanese multicenter study.
    Nishiyama M; Sekizawa A; Ogawa K; Sawai H; Nakamura H; Samura O; Suzumori N; Nakayama S; Yamada T; Ogawa M; Katagiri Y; Murotsuki J; Okamoto Y; Namba A; Hamanoue H; Ogawa M; Miura K; Izumi S; Kamei Y; Sago H
    Prenat Diagn; 2016 Dec; 36(12):1121-1126. PubMed ID: 27760457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.